Tuesday - February 10, 2026
OU-Industry Collaboration Harnesses AI to Accelerate Antibody Drug Production
February 09, 2026
NORMAN, Oklahoma, Feb. 9 -- The University of Oklahoma issued the following news:

* * *

OU-Industry Collaboration Harnesses AI to Accelerate Antibody Drug Production

*

NORMAN, Okla. - As instigators of immunity, monoclonal antibodies are marvels of modern medicine, lab-made proteins that can treat cancers, autoimmune diseases, and many other conditions. With the market for these therapies forecast to double by 2030, it might seem that the only . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products